Ultherapy for Facial, Jawline, and Neck Skin Laxity
I cannot provide evidence-based recommendations for Ultherapy as the provided evidence exclusively addresses unrelated topics (gout management and PUVA therapy for dermatologic conditions), with no guidelines or drug labels specific to microfocused ultrasound with visualization (Ultherapy).
However, based on the available research evidence, I can offer the following information:
Indications
Ultherapy is effective for adults with mild-to-moderate facial, jawline, and neck skin laxity. 1, 2
- Best suited for patients with mild-to-moderate skin and soft tissue laxity 2
- Effective for brow lifting (0.47-1.7 mm elevation) and submental area reduction (26-45 mm² decrease) 1
- Can improve neck and décolletage lines and wrinkles 3
- Approximately 92% of patients demonstrate improvement in skin tightening and/or wrinkle reduction at 90 days post-treatment 1
Contraindications and Relative Contraindications
Excessive skin laxity and BMI >30 are relative contraindications, as treatment efficacy declines significantly in these populations. 1, 4
- No change detected in 54.5% of patients with BMI >30 kg/m², compared to only 12.2% in patients with BMI ≤30 kg/m² 4
- Patients with severe skin laxity and marked platysmal banding should be considered for surgical treatment instead 2
Procedure Details
The device uses microfocused ultrasound to create thermal coagulation points at depths up to 5 mm in the dermis and subdermis, reaching temperatures >60°C. 2
- Treatment utilizes 7 MHz and 10 MHz transducers depending on target depth 3
- High-resolution ultrasound imaging allows visualization of tissue planes to 8 mm depth 2
- Targets the superficial musculoaponeurotic system (SMAS) and platysma to achieve lifting 2
- Brief discomfort during treatment can be minimized with oral NSAIDs 2
- Average procedural pain scores range from 5.68 (cheek) to 6.53 (submandibular region) on a 0-10 scale 4
Adverse Effects
Treatment causes transient erythema with or without edema; other adverse effects are rare (2%). 1
- Common: Transient erythema, edema, occasional bruising 2
- Rare (2%): Dysesthesia (numbness or hypersensitivity), mandibular burns, striations, contact dermatitis 1
- Wheals may occur but resolve without intervention 4
- No severe adverse events reported in clinical trials 4
Expected Outcomes and Timeline
Improvements continue to develop over time, with patient-reported satisfaction increasing from 42% at 90 days to 53% at 360 days. 1
- Results assessed at 90 days show 63.6% of patients with quantitative improvement 4
- At 90 days, 65.6% of patients perceived improvement in lower face/neck skin laxity 4
- Effects are gradual due to neocollagenesis and elastin remodeling 4
Alternative Treatments
For mild-to-moderate laxity, alternatives include radiofrequency with microneedling, botulinum toxin for platysmal bands, and fractional ablative lasers. 5
- Botulinum toxin (onabotulinumtoxinA) for dynamic platysmal bands and jawline definition 6
- Monopolar radiofrequency for skin tightening and collagen remodeling 7
- Hyaluronic acid fillers (VYC-25L) for jawline definition restoration 8
- Combination therapy: Ultherapy with diluted calcium hydroxylapatite for neck and décolletage 3
- Surgical options for severe laxity 2